GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 679 filers reported holding GLAXOSMITHKLINE PLC in Q4 2013. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $324,000 | -85.0% | 7,050 | -82.5% | 0.14% | -82.2% |
| Q2 2014 | $2,161,000 | +0.5% | 40,400 | +0.4% | 0.79% | -5.4% |
| Q1 2014 | $2,151,000 | +20.8% | 40,250 | +20.7% | 0.83% | +18.7% |
| Q4 2013 | $1,781,000 | -19.2% | 33,350 | -24.1% | 0.70% | -20.8% |
| Q3 2013 | $2,204,000 | +0.4% | 43,930 | 0.0% | 0.88% | -8.0% |
| Q2 2013 | $2,195,000 | – | 43,930 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 5,993,336 | $264,217,000 | 32.64% |
| Black Creek Investment Management Inc. | 10,373,943 | $457,491,000 | 12.20% |
| KAHN BROTHERS GROUP INC | 1,438,569 | $63,440,893,000 | 8.71% |
| EQUITY INVESTMENT CORP | 2,932,078 | $129,305,000 | 4.68% |
| JET CAPITAL INVESTORS L P | 400,000 | $17,640,000 | 4.67% |
| Eversept Partners, LP | 1,503,700 | $66,313,170 | 4.24% |
| NKCFO LLC | 269,500 | $11,885,000 | 3.82% |
| Camber Capital Management LP | 2,500,000 | $110,250,000 | 3.79% |
| CLIFFORD CAPITAL PARTNERS LLC | 113,866 | $5,021,000 | 3.75% |
| Robinson Value Management, Ltd. | 97,677 | $4,308,000 | 3.54% |